Qiagen Draws Early Takeover Interest From EQT, Advent

Qiagen NV, the European molecular testing company, is drawing early takeover interest from firms including EQT AB and Advent, people familiar with the matter said.

You are being sent to the original publisher. FX Radar keeps this reference for market context and source discovery.